Prospective Randomized Controlled Trial to evaluate effectiveness of adjuvant Silodosin for Improving the Stone-Free Rate after Extracorporeal Shock Wave Lithotripsy in Renal Stones

Status

Unknown

Phases

Phase 3

Study type

Interventional

Source

TCTR

Registry ID

TCTR20230502002

Enrollment

100

Registered

2023-05-02

Start date

2023-05-03

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stone free status Stone free status

Interventions

Prescribe silodosin,No give silodosin

Experimental Drug,No Intervention No treatment

Silodosin,No give silodosin

Eligibility

Sex/Gender

All

Age

18 Years to 90 Years

Inclusion criteria

Inclusion criteria: Renal stone patient

Exclusion criteria

Exclusion criteria: on anticoagulant

Design outcomes

Primary

Measure	Time frame
Stone free status one month Stone free status	—

Secondary

Measure	Time frame
complication one month rate of visit at emergency unit	—

Countries

Thailand

Contacts

Public Contactphanpon leelahawong

Rayong hospital

chinnake@gmail.com0805850991

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026